FDA Fruit Vape Approval Questioned: Study Shows No Quitting Aid

A recent memo from the Food and Drug Administration (FDA) has raised serious questions about the agency's decision to authorize fruit-flavored e-cigarettes. The document indicates that these flavored vapes were not significantly more effective at helping smokers quit traditional cigarettes than their tobacco-flavored counterparts.

This revelation is expected to heighten scrutiny of the FDA's controversial approval, which marked the first time the agency endorsed fruit-flavored vapes as a harm-reduction tool. Health groups and lawmakers have demanded explanations for the decision.

The FDA's authorization process, detailed in the memo, appears to have sidestepped typical concerns regarding flavored vapes. Regulators acknowledged data deficiencies from manufacturer Glas Inc. but proceeded with approval.

The memo noted that while smokers using Glas vapes showed increased complete switching over three months, there were no statistically significant differences between fruit and tobacco flavors. This contrasts with previous approvals for menthol flavors from Juul and NJOY.

Notably, FDA regulators stated the Glas fruit vapes did not need to demonstrate added adult benefit due to an age-verifying cellphone app requirement. However, this contradicts recent FDA guidance emphasizing a high evidentiary burden for fruit flavors due to child appeal.

The FDA's documentation for Glas was unusually brief, lacking key details found in prior, more extensive memos for products like Juul's menthol vapes. The memo was also posted more than a month after the products' approval.

Members of Congress have already voiced concerns, with ten Democratic senators sending a letter criticizing the decision. Glas Inc.'s application navigated a complex path, initially rejected before an FDA reversal and subsequent approval during a commissioner's final week.